Christoph Röllig

88PUBLICATIONS
453CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (88)

|Aug 14, 2026
Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory mIDH1 AML.

|Jul 19, 2026
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study.

|Jun 25, 2026
Genomic landscape of acute myeloid leukemia in adolescents and young adults.

|Jun 23, 2026
Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

Pageof 15

Frequent Collaborators

29 joint publications

Sarah Bertoli

15 joint publications

Pierre-Yves Dumas

15 joint publications

François Vergez

15 joint publications

Eric Delabesse